According to the new report of the SCIMAGO database in year 6, Iran has gained a special place in the number of scieific articles in the number of scieific articles, according to the new report of the SCIMAGO. Iran is ranked first among the couries of the region, with Türkiye, Saudi Arabia and Egypt in the next place. These statistics show Iran’s dramatic progress in science and technology.
It was a turning poi in Iran’s biotechnology developme from 1 to 5 years. During this period, Iran became a purely researcher from a scholarly producer of knowledge -based products and ery io global markets. Institutions such as the headquarters of science, biological technologies and stem cells played a key supportive role in the fledgling industry. Academic research we beyond the article and thesis and eered the commercialization phase, indicating a link between science and economics to meet the needs of the coury.
Production of “Ierferon Alpha” by Iranian experts
The production of ierferon alpha, the first Iranian biotechnology drug to treat hepatitis, took place during this period, which is an importa step in the coury’s pharmaceutical self -sufficiency.
With the increase in the publication of extensive articles and support, Iran has made significa improvemes in the field of biotechnology and health in the field of biotechnology and health, and the eighth world rank in the field of rehabilitation medicine. Iran has ranked fifth in Asia and ranked first in the region by producing more than 5 biotechnology -based products in the fields of medicine, agriculture, industry and environme.
These achievemes represe the mass production of advanced and vital products by domestic experts and promise a bright future for the Iranian knowledge -based industry.
(Tagstotranslate) Vice Preside of Technology and Economics of Presideial Knowledge Based (T) Knowledge -Based Companies (T) Biotechnology
